<p><h1>Vacuum-assisted Biopsy Devices Market Size: Growth Outlook from 2023 to 2030, projecting at Market's Trends Analysis by Application, Regional Outlook, and Revenue</h1></p><p><strong>Vacuum-assisted Biopsy Devices Market Analysis and Latest Trends</strong></p>
<p><p>Vacuum-assisted biopsy devices are medical devices used for the minimally invasive removal of tissue samples from the body for diagnostic purposes. These devices utilize vacuum pressure to extract tissue samples quickly and efficiently, reducing pain and scarring for patients compared to traditional surgical biopsies.</p><p>Market Analysis:</p><p>The vacuum-assisted biopsy devices market is expected to experience significant growth during the forecast period. Key factors driving this growth include increasing prevalence of breast cancer, technological advancements in biopsy devices, and rising demand for minimally invasive procedures. Additionally, the growing geriatric population and the need for early and accurate diagnosis of various diseases are also contributing to the market's expansion.</p><p>Furthermore, the market is witnessing a surge in demand for vacuum-assisted biopsy devices due to their advantages, such as shorter procedure times, minimal invasiveness, reduced complications, and improved sample quality. These factors are leading to a rapid adoption of vacuum-assisted biopsy procedures by healthcare professionals.</p><p>Latest Trends:</p><p>One of the latest trends in the vacuum-assisted biopsy devices market is the increasing use of image-guided vacuum-assisted biopsy procedures. This approach enables better visualization and targeting of lesions, resulting in improved accuracy and higher success rates. Moreover, the integration of advanced imaging technologies, such as MRI and ultrasound, with vacuum-assisted biopsy devices is further enhancing the diagnostic capabilities of these devices.</p><p>Another emerging trend is the development of vacuum-assisted biopsy devices with larger sample collection capabilities. This enables pathologists to obtain larger tissue samples, which can provide more comprehensive and accurate diagnostic information. Additionally, the development of handheld and portable vacuum-assisted biopsy devices is enabling their usage in a wider range of settings, including clinics and ambulatory surgical centers.</p><p>In conclusion, the vacuum-assisted biopsy devices market is expected to demonstrate steady growth during the forecast period. Advancements in technology, increasing prevalence of diseases, and the need for minimally invasive procedures are key drivers of market expansion. The integration of advanced imaging technologies and the development of devices with larger sample collection capabilities are some of the latest trends in this market. The projected CAGR of 8% indicates a promising future for the vacuum-assisted biopsy devices market.</p></p>
<p><strong>Get a Sample PDF of the Report:&nbsp; <a href="https://www.reliableresearchreports.com/enquiry/request-sample/1124730">https://www.reliableresearchreports.com/enquiry/request-sample/1124730</a></strong></p>
<p>&nbsp;</p>
<p><strong>Vacuum-assisted Biopsy Devices Major Market Players</strong></p>
<p><p>The vacuum-assisted biopsy devices market is highly competitive, with several key players dominating the industry. Some of the major players in this market are BD (Becton, Dickinson and Company), Mammotome (a division of Leica Biosystems), and Hologic.</p><p>BD is a global medical technology company that specializes in medical devices, instrument systems, and reagents. The company has a rich history that dates back over 100 years, and it is known for its commitment to innovation and quality. BD entered the vacuum-assisted biopsy devices market with the acquisition of C. R. Bard, Inc. in 2017. This acquisition significantly expanded BD's product portfolio and market presence. In 2020, BD reported annual sales revenue of $17.3 billion.</p><p>Mammotome, a division of Leica Biosystems, is a leading provider of breast biopsy solutions. Mammotome has been in the market for more than 20 years and has a strong reputation for its innovative and reliable products. The company offers a range of vacuum-assisted biopsy devices that are used for breast cancer diagnosis and treatment. While specific sales revenue figures for Mammotome are not readily available, it is estimated that Leica Biosystems generated sales revenue of over $1 billion in 2020.</p><p>Hologic is another prominent player in the vacuum-assisted biopsy devices market. The company is a leading global healthcare and diagnostics company that develops innovative products for women's health, including breast biopsy solutions. Hologic's vacuum-assisted biopsy devices are known for their high precision and reliability. In 2020, Hologic reported total sales revenue of $3.77 billion.</p><p>The vacuum-assisted biopsy devices market has been experiencing steady growth in recent years. This growth can be attributed to factors such as increasing awareness about the importance of early cancer detection, advancements in technology, and rising demand for minimally invasive procedures. According to a report by Market Research Future, the global vacuum-assisted biopsy devices market is expected to reach a market size of approximately $841 million by 2023, growing at a CAGR of 5.2% during the forecast period.</p><p>In conclusion, the vacuum-assisted biopsy devices market is highly competitive, with BD, Mammotome, and Hologic being key players in the industry. These companies have a strong track record of innovation, quality, and market presence. The market size for vacuum-assisted biopsy devices is expected to grow significantly in the coming years, driven by factors such as increasing cancer prevalence and advancements in technology.</p></p>
<p>&nbsp;</p>
<p><strong>What Are The Key Opportunities For Vacuum-assisted Biopsy Devices Manufacturers?</strong></p>
<p><p>The vacuum-assisted biopsy devices market is experiencing rapid growth due to various factors such as the increasing incidence of breast cancer, growing awareness regarding early detection and diagnosis, and technological advancements in biopsy devices. The market is projected to witness significant growth in the coming years, with a CAGR of around 7%. Factors such as the rising demand for minimally invasive procedures and the growing geriatric population are expected to drive market growth. Additionally, the development of advanced imaging technologies and a focus on improving healthcare infrastructure are likely to contribute to the market's future outlook.</p></p>
<p><strong>Inquire or Share Your Questions If Any Before Purchasing This Report: <a href="https://www.reliableresearchreports.com/enquiry/pre-order-enquiry/1124730">https://www.reliableresearchreports.com/enquiry/pre-order-enquiry/1124730</a></strong></p>
<p>&nbsp;</p>
<p><strong>Market Segmentation</strong></p>
<p><strong>The Vacuum-assisted Biopsy Devices Market Analysis by types is segmented into:</strong></p>
<p><ul><li>9-12G</li><li>Below 9G</li><li>Above 12G</li></ul></p>
<p><p>The vacuum-assisted biopsy devices market can be classified into three types based on the gauge size of the needle used for the procedure. 9-12G refers to needle sizes ranging from 9 to 12 gauge, below 9G indicates needle sizes smaller than 9 gauge, and above 12G represents needle sizes larger than 12 gauge. These different gauge sizes enable healthcare professionals to choose the appropriate device based on the specific needs of the patient and the targeted tissue sample, ensuring accurate and efficient biopsy procedures.</p></p>
<p><strong>Purchase this Report:&nbsp;<a href="https://www.reliableresearchreports.com/purchase/1124730">https://www.reliableresearchreports.com/purchase/1124730</a></strong></p>
<p>&nbsp;</p>
<p><strong>The Vacuum-assisted Biopsy Devices Market Industry Research by Application is segmented into:</strong></p>
<p><ul><li>Hospitals</li><li>Academic and Research Institutes</li><li>Diagnostic and Imaging Centers</li></ul></p>
<p><p>Vacuum-assisted biopsy devices find applications in various healthcare settings such as hospitals, academic and research institutes, and diagnostic and imaging centers. These devices are used for minimally invasive biopsy procedures, enabling precise tissue sampling for diagnosis of breast abnormalities and other lesions. Hospitals utilize these devices for improved patient care and accurate diagnosis, while academic and research institutes benefit from their use in studies and advancements in biopsy techniques. Diagnostic and imaging centers also employ these devices to enhance their diagnostic capabilities, improving patient outcomes.</p></p>
<p>&nbsp;</p>
<p><strong>In terms of Region, the Vacuum-assisted Biopsy Devices Market Players available by Region are:</strong></p>
<p>
    <p> <strong> North America: </strong>
        <ul>
            <li>United States</li>
            <li>Canada</li>
        </ul>
        </p> 
    <p> <strong> Europe: </strong>
        <ul>
            <li>Germany</li>
            <li>France</li>
            <li>U.K.</li>
            <li>Italy</li>
            <li>Russia</li>
        </ul>
        </p> 
    <p> <strong> Asia-Pacific: </strong>
        <ul>
            <li>China</li>
            <li>Japan</li>
            <li>South Korea</li>
            <li>India</li>
            <li>Australia</li>
            <li>China Taiwan</li>
            <li>Indonesia</li>
            <li>Thailand</li>
            <li>Malaysia</li>
        </ul>
        </p> 
    <p> <strong> Latin America: </strong>
        <ul>
            <li>Mexico</li>
            <li>Brazil</li>
            <li>Argentina Korea</li>
            <li>Colombia</li>
        </ul>
        </p> 
    <p> <strong> Middle East & Africa: </strong>
        <ul>
            <li>Turkey</li>
            <li>Saudi</li>
            <li>Arabia</li>
            <li>UAE</li>
            <li>Korea</li>
        </ul>
    </p>
    </p>
<p><p>The vacuum-assisted biopsy devices market is expected to witness significant growth in several regions including North America (NA), Asia-Pacific (APAC), Europe, USA, and China. North America is anticipated to dominate the market share, owing to the rising prevalence of breast cancer and the presence of advanced healthcare infrastructure. Europe is likely to follow due to the increasing adoption of minimally invasive procedures. APAC and China are projected to witness substantial growth due to the expanding healthcare sector and rising awareness regarding early disease detection. Exact market share percentages cannot be determined without extensive market analysis.</p></p>
<p><strong>Purchase this Report: <a href="https://www.reliableresearchreports.com/purchase/1124730">https://www.reliableresearchreports.com/purchase/1124730</a></strong></p>
<p>&nbsp;<strong>Get a Sample PDF of the Report:&nbsp;&nbsp;<a href="https://www.reliableresearchreports.com/enquiry/request-sample/1124730">https://www.reliableresearchreports.com/enquiry/request-sample/1124730</a></strong></p>
<p><strong></strong></p>
<p><p><a href="https://medium.com/@board.cry.ball/oatmeal-market-size-growth-forecast-2023-2030-4e144d5edc38">Oatmeal Market</a></p><p><a href="https://medium.com/@emilywest91/electrophoresis-systems-market-size-growth-forecast-2023-2030-078ac699b2c2">Electrophoresis Systems Market</a></p><p><a href="https://github.com/PeterParrish5/Market-Research-Report-List-1/blob/main/x-ray-inspection-system-market.md">X-ray Inspection System Market</a></p><p><a href="https://www.linkedin.com/pulse/decoding-solvent-free-epoxy-market-deep-dive-latest-trends-twzte/">Solvent Free Epoxy Market</a></p><p><a href="https://github.com/WillieWoodard/Market-Research-Report-List-1/blob/main/release-liner-market.md">Release Liner Market</a></p></p>